1. Adelaide Research & Scholarship

Browsing "Pharmacology" by Author Irvine, R.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 12 to 31 of 42 < previous   next >
PreviewIssue DateTitleAuthor(s)
2005Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemideFreezer, A.; Salem, A.; Irvine, R.
2005Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulationJaehne, E.; Salem, A.; Irvine, R.
2001Effects of testosterone propionate and nandrolone decanoate on body composition and lipoprotein concentrations in the ratLewanowitsch, T.; Irvine, R.
2013Evaluation of pre-analysis loss of dependent drugs in wastewater: stability and binding assessmentsChen, C.; Kostakis, C.; Irvine, R.; Felgate, P.; White, J.
2007In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA) but not 3 4-methylenedioxymethamphetamine (MDMA) leads to long-lasting deficits in serotonin transporter functionCallaghan, P.; Owens, W.; Javors, M.; Sanchez, T.; Jones, D.; Irvine, R.; Daws, L.
2011Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depressionJaehne, E.; Majumder, I.; Salem, A.; Irvine, R.
2013Increases in use of novel synthetic stimulant are not directly linked to decreased use of 3,4-methylenedioxy-N-methylamphetamine (MDMA)Chen, C.; Kostakis, C.; Irvine, R.; White, J.
2011Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysisChen, C.; Kostakis, C.; Harpas, P.; Felgate, P.; Irvine, R.; White, J.
1999Mechanisms of fatal opioid overdose.White, J.; Irvine, R.
2010Model of methadone-induced hyperalgesia in rats and effect of memantineHay, J.; Kaboutari, J.; White, J.; Salem, A.; Irvine, R.
2003Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for m, d, k and opiod receptors in mouse brain homogenatesLewanowitsch, T.; Irvine, R.
2002Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawalLewanowitsch, T.; Irvine, R.
2006Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: Relationship to lasting effects on brain serotonin neuronsMechan, A.; Yuan, J.; Hatzidimitriou, G.; Irvine, R.; McCann, U.; Ricaurte, G.
2007Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para -methoxyamphetamine-induced hyperthermiaJaehne, E.; Salem, A.; Irvine, R.
2011Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' usersMorefield, K.; Keane, M.; Felgate, P.; White, J.; Irvine, R.
2006Plasma drug concentrations and physiological measures in 'dance party' participantsIrvine, R.; Keane, M.; Felgate, P.; McCann, U.; Callaghan, P.; White, J.
2001Poisoning with the recreational drug paramethoxyamphetamine ("death")Ling, L.; Marchant, C.; Buckley, N.; Prior, M.; Irvine, R.
2011Population drug use in Australia: A wastewater analysisIrvine, R.; Kostakis, C.; Felgate, P.; Jaehne, E.; Chen, C.; White, J.
2007Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase a inhibitorHewton, R.; Salem, A.; Irvine, R.
2001Precipitated withdrawal following codeine administration is dependent on CYP genotypeChew, M.; White, J.; Somogyi, A.; Bochner, F.; Irvine, R.
Showing results 12 to 31 of 42 < previous   next >